Melanoma spot - Causes, Treatment & When to See a Doctor

```html

What is Melanoma spot?

Melanoma is a malignant tumor that originates from melanocytes, the pigment‑producing cells in the skin. A “melanoma spot” refers to a skin lesion that shows features suggestive of melanoma, such as asymmetry, irregular borders, multiple colors, diameter larger than 6 mm, or evolution over time. While many benign moles (nevi) share some of these characteristics, a melanoma spot requires prompt medical attention because melanoma is the deadliest form of skin cancer if not caught early.

According to the Mayo Clinic, early‑stage melanoma is often curable with surgery alone, but advanced disease can spread to lymph nodes, organs, and become life‑threatening. Recognizing suspicious spots and seeking evaluation early dramatically improves survival rates (5‑year survival > 99 % for stage 0/I vs. < 30 % for stage IV).

Common Causes

Melanoma does not arise from a single cause; rather, a combination of genetic, environmental, and lifestyle factors increases risk. The following conditions or risk factors are most frequently linked to the development of melanoma spots:

• Excessive UV radiation – chronic sun exposure and intermittent intense exposure (sunburns).
• Fair skin, red or blonde hair, blue/green eyes – less melanin provides less natural protection.
• Family history of melanoma – inherited genetic mutations (e.g., CDKN2A, BRAF).
• Personal history of melanoma or other skin cancers – the risk of new lesions rises.
• Numerous or atypical moles (dysplastic nevi) – especially those larger than 5 mm with irregular borders.
• Weakened immune system – organ transplant recipients, HIV, or long‑term immunosuppressive therapy.
• Exposure to certain chemicals – such as arsenic, polycyclic aromatic hydrocarbons, or some pesticides.
• Radiation therapy – therapeutic radiation can induce secondary skin cancers.
• Hormonal factors – pregnancy or hormone‑replacement therapy may accelerate growth of existing atypical moles.
• Rare genetic syndromes – e.g., xeroderma pigmentosum, familial atypical multiple mole melanoma (FAMMM) syndrome.

Associated Symptoms

While many melanoma spots are painless and asymptomatic, several accompanying signs may alert a patient to a concerning lesion:

• Itching, tenderness, or pain in the spot.
• Bleeding or oozing without obvious injury.
• Crusting or ulceration on the surface.
• Rapid increase in size, shape, or color over weeks to months.
• Elevation above the surrounding skin (a “raised” or “nodule” appearance).
• Presence of new spots near an existing melanoma (indicates field‑change effect).
• Systemic symptoms (rare in early disease) – unexplained weight loss, fatigue, or night sweats may suggest metastasis.

When to See a Doctor

Because melanoma can be curable only when caught early, any of the following warrants prompt evaluation by a dermatologist or primary‑care provider:

• Any new spot that does not fit the “ABCDE” criteria for benign nevi.
• Changes in an existing mole (size, shape, color, or sensation).
• Bleeding, crusting, or ulceration of a lesion.
• Persistent itching or pain in a spot.
• More than 50 moles or a personal/family history of melanoma.
• History of severe sunburns, especially before age 18.

If you are uncertain, most dermatology offices offer a quick tele‑dermatology consult or a same‑day appointment for suspicious lesions.

Diagnosis

Diagnosing a melanoma spot involves a stepwise approach that blends visual assessment with histologic confirmation:

1. Clinical Examination – “ABCDEF” rule

1. Asymmetry – one half does not match the other.
2. Border – irregular, scalloped, or poorly defined.
3. Color – shades of brown, black, tan, red, blue, or white.
4. Diameter – > 6 mm (about the size of a pencil eraser).
5. Evolving – any change over time.
6. Fever – persistent itching or tenderness.

2. Dermoscopy

Using a handheld magnifying device, clinicians can visualize pigment patterns and vascular structures that are invisible to the naked eye. Dermoscopy improves diagnostic accuracy by 10‑30 % compared with visual inspection alone (source: CDC).

3. Biopsy

The definitive diagnosis requires tissue sampling. Common techniques include:

• Excisional biopsy – complete removal of the lesion with a narrow margin; preferred for lesions < 1 cm.
• Punch biopsy – cylindrical core; used when the lesion is large or in a cosmetically sensitive area.
• Incisional biopsy – partial removal; reserved for very large tumors.

The specimen is examined by a dermatopathologist for Breslow thickness, ulceration, mitotic rate, and other prognostic features.

4. Staging Tests (if invasive melanoma is confirmed)

• Sentinel lymph‑node biopsy (SLNB) – identifies microscopic spread to nearby nodes.
• Imaging (CT, PET/CT, MRI) – assesses distant metastasis in higher‑stage disease.

Treatment Options

Treatment is individualized based on tumor thickness, location, and stage. The goal is to eradicate the primary tumor, prevent spread, and preserve function and appearance.

1. Surgical Management

• Wide local excision (WLE) – removal of the melanoma with a 0.5–2 cm safety margin, depending on Breslow depth.
• Mohs micrographic surgery – tissue‑sparing technique for melanoma in cosmetically sensitive areas (e.g., face).
• Sentinel lymph‑node biopsy – performed at the time of WLE for tumors ≥ 0.8 mm thickness or with high‑risk features.

2. Adjuvant Therapies

When there is a high risk of recurrence, additional treatment may be recommended after surgery:

• Immunotherapy – checkpoint inhibitors such as pembrolizumab (Keytruda) or nivolumab (Opdivo) improve disease‑free survival (NIH, 2023).
• Targeted therapy – BRAF inhibitors (vemurafenib, dabrafenib) combined with MEK inhibitors for tumors harboring BRAF V600E/K mutations.
• Radiation therapy – reserved for high‑risk nodal basins or inoperable disease.

3. Systemic Therapy for Advanced Disease

• Combination immunotherapy (nivolumab + ipilimumab) for metastatic melanoma.
• Oncolytic virus therapy (Talimogene laherparepvec – T-VEC) for injectable cutaneous lesions.
• Clinical trials – enrollment in studies investigating novel agents is encouraged.

4. Home and Supportive Care

• Wound care instructions after surgery – keep the area clean, change dressings as directed.
• Sun‑protection measures (broad‑spectrum SPF 30+ sunscreen, protective clothing).
• Psychosocial support – counseling or support groups for patients coping with a cancer diagnosis.
• Regular skin self‑exams and follow‑up appointments as advised.

Prevention Tips

While genetics cannot be changed, most melanoma cases are linked to UV exposure, which is modifiable.

• Apply sunscreen daily – use broad‑spectrum SPF 30 or higher, reapply every 2 hours outdoors.
• Seek shade during peak sun hours (10 am–4 pm).
• Wear protective clothing – long‑sleeved shirts, wide‑brim hats, UV‑blocking sunglasses.
• Avoid indoor tanning beds – they emit UVA radiation that increases melanoma risk.
• Perform regular skin checks – monthly self‑examinations and annual dermatologist exams.
• Know your family history – inform your doctor of any relatives with melanoma.
• Protect children – start sun‑safe habits early; sunscreen should be used on infants > 6 months.
• Consider chemoprevention – for very high‑risk individuals, oral nicotinamide (vitamin B3) has shown modest reduction in non‑melanoma skin cancers (Cleveland Clinic, 2022) – discuss with your physician.

Emergency Warning Signs

Key Take‑aways

Melanoma spots are potentially life‑threatening lesions that demand vigilance. Recognizing the “ABCDE/F” warning signs, protecting skin from UV damage, and obtaining prompt dermatologic evaluation are the cornerstones of early detection. Modern treatments—including surgery, immunotherapy, and targeted agents—have dramatically improved survival, especially when melanoma is caught before it spreads. If you notice any suspicious change in your skin, do not delay—schedule an appointment today.

References:

1. Mayo Clinic. Melanoma – Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/melanoma/symptoms-causes/syc-20374884 (accessed May 2026).
2. Centers for Disease Control and Prevention. Skin Cancer Prevention. https://www.cdc.gov/cancer/skin/basic_info.htm (accessed May 2026).
3. National Institutes of Health. Immunotherapy for melanoma. https://www.nih.gov/news-events/nih-research-matters/immunotherapy-melanoma (2023).
4. World Health Organization. Melanoma and UV radiation. https://www.who.int/uv/health/melanoma (2022).
5. Cleveland Clinic. Preventing skin cancer with nicotinamide. https://my.clevelandclinic.org/health/articles/21099-nicotinamide-and-skin-cancer-prevention (2022).
6. American Academy of Dermatology. Dermoscopic evaluation of pigmented lesions. https://www.aad.org/public/diseases/skin-cancer/melanoma/diagnosis (2024).

```